Recurrence interval affects survival after local relapse of oral cancer
- PMID: 19095488
- DOI: 10.1016/j.oraloncology.2008.10.011
Recurrence interval affects survival after local relapse of oral cancer
Abstract
The aim of this study was to investigate whether the recurrence interval influenced survival rate of patients with relapse of oral squamous cell carcinoma (OSCC). From 1992 to 2006, a total of 773 patients with OSCC treated at the Department of Oral and Maxillofacial Plastic Surgery of the Ruhr-University Bochum were reviewed. Statistical analysis included descriptive statistics, Kaplan-Meier survival analyses, receiver operating characteristic, the Youden-Index and analysis using the log-rank test and Cox-regression. The overall recurrence rate was 23.9%. Local recurrence was more common (64.9%) than locoregional recurrence (25.1%). Patients with relapse more than 18 months after completion of their primary treatment had significantly improved survival rates compared with those who relapsed within 18 months of initial treatment (20.5% vs 42.3%). A significant difference was noted in the survival rate between patients with local and locoregional recurrence (37.5% vs 21.5%). Overall survival rate after salvage was 31.9%. The interval from initial treatment to recurrence is an independent prognostic factor for OSCC patients. Patients with a recurrence interval of 18 months had a statistically significant higher probability of death than those with a recurrence interval >18 months. This information can help inform salvage treatment strategies and provide a classification of early and late recurrences.
Similar articles
-
Impact of recurrence interval on survival of oral cavity squamous cell carcinoma patients after local relapse.Otolaryngol Head Neck Surg. 2007 Jan;136(1):112-8. doi: 10.1016/j.otohns.2006.07.002. Otolaryngol Head Neck Surg. 2007. PMID: 17210345
-
Salvage therapy in relapsed squamous cell carcinoma of the oral cavity: how and when?Cancer. 2008 Jan 1;112(1):94-103. doi: 10.1002/cncr.23142. Cancer. 2008. PMID: 18022917
-
Salvage treatment for recurrent oral squamous cell carcinoma.J Craniofac Surg. 2009 Jul;20(4):1093-6. doi: 10.1097/SCS.0b013e3181abb307. J Craniofac Surg. 2009. PMID: 19521259
-
Survival analysis and risk factors for recurrence in oral squamous cell carcinoma: does surgical salvage affect outcome?J Oral Maxillofac Surg. 2010 Jun;68(6):1270-5. doi: 10.1016/j.joms.2009.11.016. Epub 2010 Mar 29. J Oral Maxillofac Surg. 2010. PMID: 20347201
-
Results of salvage treatment of the neck in patients with oral cancer.Arch Otolaryngol Head Neck Surg. 2002 Jan;128(1):58-62. doi: 10.1001/archotol.128.1.58. Arch Otolaryngol Head Neck Surg. 2002. PMID: 11784256
Cited by
-
Autofluorescence imaging in recurrent oral squamous cell carcinoma.Oral Maxillofac Surg. 2016 Mar;20(1):27-33. doi: 10.1007/s10006-015-0520-7. Epub 2015 Aug 13. Oral Maxillofac Surg. 2016. PMID: 26267490
-
Temporal and spatial patterns of recurrence in oral squamous cell carcinoma, a single-center retrospective cohort study in China.BMC Oral Health. 2023 Sep 19;23(1):679. doi: 10.1186/s12903-023-03204-7. BMC Oral Health. 2023. PMID: 37726764 Free PMC article.
-
What is the Potential Interplay between Microbiome and Tumor Microenvironment in Oral Squamous Cell Carcinomas?Asian Pac J Cancer Prev. 2022 Jul 1;23(7):2199-2213. doi: 10.31557/APJCP.2022.23.7.2199. Asian Pac J Cancer Prev. 2022. PMID: 35901324 Free PMC article. Review.
-
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.Theranostics. 2021 Jan 1;11(6):2987-2999. doi: 10.7150/thno.45157. eCollection 2021. Theranostics. 2021. PMID: 33456584 Free PMC article.
-
Opportunities and Limits in Salvage Surgery in Persistent or Recurrent Head and Neck Squamous Cell Carcinoma.Cancers (Basel). 2021 May 18;13(10):2457. doi: 10.3390/cancers13102457. Cancers (Basel). 2021. PMID: 34070089 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical